BioPharma Credit PLC
BOPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $86 | $121 | $95 |
| Short-Term Investments | $0 | $49 | $0 | $0 |
| Receivables | $32 | $20 | $20 | $10 |
| Inventory | $0 | $0 | -$0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $37 | $155 | $140 | $105 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1,162 | $1,201 | $1,224 | $1,266 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,162 | $1,201 | $1,224 | $1,266 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,200 | $1,357 | $1,364 | $1,371 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $0 | $6 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $17 | $16 | $26 | $0 |
| Total Curr. Liab. | $18 | $16 | $26 | $6 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$0 | -$1 |
| Total NC Liab. | $0 | $0 | $27 | $1 |
| Other Liabilities | $0 | $0 | -$27 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $18 | $16 | $26 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $14 | $14 | $14 | $14 |
| Retained Earnings | $561 | $720 | $717 | $743 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $607 | $607 | $607 | $607 |
| Total Equity | $1,182 | $1,341 | $1,337 | $1,364 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,200 | $1,357 | $1,364 | $1,371 |
| Net Debt | -$6 | -$86 | -$121 | -$95 |